---
author: Marisa Aigen
category: tech
date: '2025-11-21 01:00:00'
description: 'ROCKVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences
  (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company
  committed to accelerating access to innovative medicines, today announced that its
  subsidiary Visara, In‚Ä¶'
importance: 3
layout: tech_news_article
original_title: NovaBridge‚Äôs Visara Subsidiary Appoints Distinguished Ophthalmology
  Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101
  Forward
publishedAt: '2025-11-21T01:00:00+00:00'
slug: novabridges-visara-subsidiary-appoints-distinguish
source:
  emoji: üì∞
  id: null
  name: GlobeNewswire
title: NovaBridge‚Äôs Visara Subsidiary Appoints Distinguished Ophthalmology Leaders
  as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
url: https://www.globenewswire.com/news-release/2025/11/21/3192485/0/en/NovaBridge-s-Visara-Subsidiary-Appoints-Distinguished-Ophthalmology-Leaders-as-Chief-Medical-Officer-and-Scientific-Advisory-Board-Chair-to-Drive-VIS-101-Forward.html
urlToImage: https://ml.globenewswire.com/Resource/Download/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15
urlToImageBackup: https://ml.globenewswire.com/Resource/Download/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15
---

ROCKVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced that its subsidiary Visara, In‚Ä¶

---

[ƒå√≠st p≈Øvodn√≠ ƒçl√°nek](https://www.globenewswire.com/news-release/2025/11/21/3192485/0/en/NovaBridge-s-Visara-Subsidiary-Appoints-Distinguished-Ophthalmology-Leaders-as-Chief-Medical-Officer-and-Scientific-Advisory-Board-Chair-to-Drive-VIS-101-Forward.html)

**Zdroj:** üì∞ GlobeNewswire
